.png "Global Insight")
If your depression comes with a body clock that runs late — you are a night owl, you sleep longer when depressed, you wake up exhausted no matter how long you slept — you may have a distinct subtype of the illness that standard antidepressants struggle to treat. Researchers at the University of Sydney have identified what they call "circadian depression" in nearly one in four people with severe, recurrent depression, according to a study published in The British Journal of Psychiatry and covered by Nature and New Scientist.
What the study found
The team analyzed clinical and genetic data from 11,380 Australians in the nationwide Australian Genetics of Depression Study. Of those, 2,604 — about 23 percent — met the criteria for the new subtype: at least three of six body-clock features, including a seasonal pattern to the illness, sleeping at later hours, sleeping more during depressive episodes, being an evening type, feeling very tired on waking, and "social jetlag," the gap between sleep times on workdays and days off.
Crucially, this was not a general-population sample: everyone in the study had severe, recurrent or persistent depression. So the honest reading is not "one in four of all depressed people" but "roughly one in four of the hardest-to-treat cases" — which may be exactly where a new subtype matters most. People in the circadian group tended to develop depression earlier in life, reported more severe symptoms including higher levels of suicidal thoughts and mania-like experiences, and carried a higher genetic risk for ADHD as well as inflammatory and cardiovascular problems.
Why the standard pills work less well
The most clinically important finding was about treatment. People with circadian depression were significantly less likely to respond to the two most widely prescribed antidepressant classes: selective serotonin reuptake inhibitors (SSRIs), with 12 percent lower odds of a satisfactory response, and serotonin-noradrenaline reuptake inhibitors (SNRIs), 11 percent lower. They also reported more side effects. "Recognizing biological rhythm disturbances early in the diagnostic pathway could prevent years of trial-and-error prescribing," said Professor Ian Hickie, co-director of the university's Brain and Mind Centre.
The alternative, the researchers suggest, is to treat the clock itself: melatonin, melatonin-targeted antidepressants, light therapy, behavioural activation, and morning sunlight exposure all target the circadian system's own brain circuits rather than serotonin. "Depression is not a uniform illness," said first author Dr. Emiliana Tonini, "and understanding the characteristics of different subtypes means that we can give people earlier access to treatments that will be most effective for them."
One caution, flagged by Nature: the findings are preliminary. Outside experts called the work a genuinely useful contribution, but said more evidence is needed before "circadian depression" is formally recognized as a disorder or treatment guidelines change. That is how science is supposed to work — a promising signal, honestly labeled. For anyone whose depression has always marched to the rhythm of a broken body clock, though, it is a signal worth watching.
This article is general information only and is not medical advice.
Follow Global Insight for clear, verified explainers on the stories shaping our world.